113 related articles for article (PubMed ID: 20455339)
1. NSAIDs, ACE inhibitors, angiotensin II receptor antagonists, and isotretinoin: still too many pregnant women exposed.
Prescrire Int; 2010 Feb; 19(105):25. PubMed ID: 20455339
[No Abstract] [Full Text] [Related]
2. Pregnancy outcome after in utero exposure to angiotensin converting enzyme inhibitors or angiotensin receptor blockers.
Diav-Citrin O; Shechtman S; Halberstadt Y; Finkel-Pekarsky V; Wajnberg R; Arnon J; Di Gianantonio E; Clementi M; Ornoy A
Reprod Toxicol; 2011 May; 31(4):540-5. PubMed ID: 21338666
[TBL] [Abstract][Full Text] [Related]
3. [Hypertension in pregnancy. ACE inhibitors and angiotensin II receptor antagonists are contraindicated because of their potential fetotoxicity].
Partosch F; Stahlmann R
Med Monatsschr Pharm; 2011 Oct; 34(10):358-62. PubMed ID: 22010419
[No Abstract] [Full Text] [Related]
4. Adverse drug reactions during heatwaves.
Prescrire Int; 2007 Feb; 16(87):19. PubMed ID: 17326279
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous adverse effects of angiotensin-II receptor antagonists.
Prescrire Int; 2007 Feb; 16(87):21. PubMed ID: 17326283
[TBL] [Abstract][Full Text] [Related]
7. Drug-induced taste disorders.
Prescrire Int; 2008 Oct; 17(97):197-9. PubMed ID: 19536936
[TBL] [Abstract][Full Text] [Related]
8. Avoidance of ACE inhibitors or angiotensin receptor blockers among women of childbearing potential with diabetes.
Guirguis AB; Shilliday BB; Malone RM; Pignone MP
Diabetes Res Clin Pract; 2008 Jan; 79(1):e11-2. PubMed ID: 17716774
[No Abstract] [Full Text] [Related]
9. The role of ace gene polymorphism in the development of angioedema secondary to angiotensin converting enzyme inhibitors and angiotensin II receptor blockers.
Gulec M; Caliskaner Z; Tunca Y; Ozturk S; Bozoglu E; Gul D; Erel F; Kartal O; Karaayvaz M
Allergol Immunopathol (Madr); 2008; 36(3):134-40. PubMed ID: 18680700
[TBL] [Abstract][Full Text] [Related]
10. [Drug-induced nephropathy].
Shimizu H; Tanaka A; Matsuo S
Nihon Rinsho; 2007 Oct; 65 Suppl 8():549-53. PubMed ID: 18074600
[No Abstract] [Full Text] [Related]
11. Drug-induced hyperkalaemia is frequent.
Prescrire Int; 2007 Feb; 16(87):16. PubMed ID: 17323523
[TBL] [Abstract][Full Text] [Related]
12. [Iatrogenic angioedema: the role of angiotensin converting enzyme inhibitor and angiotensin II receptor blockers].
Roskiewicz F; Andriamanana I; Gras-Champel V; Andrejak M; Massy ZA
Nephrol Ther; 2007 Jun; 3(3):89-95. PubMed ID: 17540310
[TBL] [Abstract][Full Text] [Related]
13. How to ensure fetal safety when mothers use isotretinoin (Accutane).
Koren G; Pastuszak A
Can Fam Physician; 1997 Feb; 43():216-9. PubMed ID: 9040906
[No Abstract] [Full Text] [Related]
14. Fetopathy associated with exposure to angiotensin converting enzyme inhibitors and angiotensin receptor antagonists.
Quan A
Early Hum Dev; 2006 Jan; 82(1):23-8. PubMed ID: 16427219
[TBL] [Abstract][Full Text] [Related]
15. Acute monoarthritis in a patient under isotretinoin.
Dubourg G; Koeger AC; Huchet B; Rozenberg S; Bourgeois P
Rev Rhum Engl Ed; 1996 Mar; 63(3):228-9. PubMed ID: 8731245
[No Abstract] [Full Text] [Related]
16. Outpatient use of cardiovascular drugs during pregnancy.
Andrade SE; Raebel MA; Brown J; Lane K; Livingston J; Boudreau D; Rolnick SJ; Roblin D; Smith DH; Dal Pan GJ; Scott PE; Platt R
Pharmacoepidemiol Drug Saf; 2008 Mar; 17(3):240-7. PubMed ID: 18200619
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers for diabetic nephropathy: a retrospective comparison.
Robles NR; Romero B; Fernandez-Carbonero E; Sánchez-Casado E; Cubero JJ
J Renin Angiotensin Aldosterone Syst; 2009 Dec; 10(4):195-200. PubMed ID: 20026868
[TBL] [Abstract][Full Text] [Related]
18. Exposure of the elderly to potential nephrotoxic drug combinations in Belgium.
Smets HL; De Haes JF; De Swaef A; Jorens PG; Verpooten GA
Pharmacoepidemiol Drug Saf; 2008 Oct; 17(10):1014-9. PubMed ID: 18763247
[TBL] [Abstract][Full Text] [Related]
19. [Inhibition of the renin angiotensin system in pregnancy and risk of fetal malformations].
Lonati C; Morganti A
Pediatr Med Chir; 2009; 31(3):137-9. PubMed ID: 19739495
[No Abstract] [Full Text] [Related]
20. Angiotensin II receptor antagonist treatment during pregnancy.
Alwan S; Polifka JE; Friedman JM
Birth Defects Res A Clin Mol Teratol; 2005 Feb; 73(2):123-30. PubMed ID: 15669052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
